Loading clinical trials...
Loading clinical trials...
J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement for Patients With Aortic Regurgitation Therapy
Conditions
Interventions
J-VALVE Transfemoral Aortic Valve system
Commercially available surgical biological aortic valve replacement device
Locations
12
China
Beijing Anzhen Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Prince of Wales Hospital
Hong Kong, Hong Kong, China
Queen Mary Hospital
Hong Kong, Hong Kong, China
Nanjing First Hospital
Nanjing, Jiangsu, China
Start Date
March 5, 2026
Primary Completion Date
March 1, 2029
Completion Date
March 1, 2038
Last Updated
March 10, 2026
NCT07197736
NCT04126018
NCT06780241
NCT07075861
NCT05172973
NCT07398911
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions